Rare diseases
Investigational molecules
Locations
Back to Germany1 444 clinical trials in Hochheim Am Main, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer
GermanyStudy on Long-Term Effects of Iptacopan in Patients with C3 Glomerulopathy or Idiopathic Immune-Complex Membranoproliferative Glomerulonephritis
GermanyStudy on the Effectiveness and Safety of Plixorafenib (FORE8394) for Patients with Cancer Having BRAF Alterations
GermanyStudy on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients
GermanyStudy on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer
GermanyStudy of Gilteritinib, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutations Not Eligible for Intensive Treatment
GermanyStudy on Emicizumab and Drug Combination for Patients with Haemophilia A and FVIII Inhibitors
GermanyStudy on Treating Solid Tumors with Genetically Modified T-Cells (IMA203, IMA203CD8) and Nivolumab for Patients with Recurrent or Refractory Conditions
GermanyStudy on the Effects of Cyclosporine A in Patients with Takotsubo Syndrome
GermanyStudy of trabectedin alone versus trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment
GermanyStudy on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older
GermanyStudy of Elritercept for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes (MDS)
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Gaucher disease and Niemann-Pick disease, exploring new therapeutic approaches for these challenging genetic conditions. Studies aim to evaluate novel treatments for improving neurological symptoms and overall patient outcomes.
Clinical investigations evaluating venglustat and nizubaglustat's effectiveness in managing disease progression.
Research centered on treating Mucopolysaccharidosis Type II (Hunter Syndrome) and Pompe disease, with multiple studies investigating innovative enzyme replacement therapies and novel drug combinations.
Evaluation of treatments like JR-141 and cipaglucosidase alfa for improved patient outcomes.
Studies focused on preventing respiratory syncytial virus infections in older adults, with particular attention to vaccine development and immune response assessment.
Investigation of revaccination strategies and long-term protection against respiratory infections.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
